Prevalence of Epstein–Barr Virus in patients with inflammatory bowel disease
A study in the latest issue of the Alimentary Pharmacology & Therapeutics prospectively examines the prevalence of Epstein–Barr Virus in a population of patients with inflammatory bowel disease.
fiogf49gjkf04
The Epstein–Barr Virus (EBV) is truly prolific, with a prevalence of more than 90% in the adult h
Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.
By continuing to browse this site you agree to us using cookies as described in our
standard cookie policy .